Skip to main content
DataMetrex AI Limited logo

DataMetrex AI Limited — Investor Relations & Filings

Ticker · DM ISIN · CA23804R1007 LEI · 5299005WDQ2U42BRMZ83 TSXV Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 737 across all filing types
Latest filing 2026-05-22 Regulatory Filings
Country CA Canada
Listing TSXV DM

About DataMetrex AI Limited

https://www.datametrex.com/

DataMetrex AI Limited is a technology company specializing in the collection, analysis, and presentation of structured and unstructured data utilizing Machine Learning and Artificial Intelligence. Through its wholly-owned subsidiary, Nexalogy, the company develops predictive and preventive technologies designed to support corporate operational goals, including Health and Safety initiatives. DataMetrex focuses on fast-moving verticals such as cybersecurity and telehealth, offering cloud-based software solutions, including plug-and-play systems for retail vendors.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings Classification · 85% confidence The document is a business news release announcing that the company’s subsidiary has achieved teaching facility status and detailing physician additions. It does not contain financial statements, voting results, management changes, financing details, or any formal report. It is a general corporate announcement. It falls under the fallback category for miscellaneous regulatory/press filings.
2026-05-22 English
News release - English.pdf
Regulatory Filings Classification · 75% confidence The document is a corporate press release announcing Datametrex’s expansion of its patent monetization strategy to include quantum-resilient encryption technologies. It does not present financial results (ruling out Earnings Release, Interim Report, Annual Report, etc.), does not concern board changes, dividends, financing, legal proceedings, or other specific categories. It is a general regulatory news release filed via Access Newswire, fitting the fallback category for miscellaneous regulatory announcements. Therefore, it should be classified as a Regulatory Filing (RNS).
2026-04-24 English
News release - English.pdf
Regulatory Filings Classification · 45% confidence The document is a press release announcing that Datametrex has received $6M of purchase orders from a Fortune 500 conglomerate. It is not an earnings release or full financial report, nor is it a capital financing or corporate governance document. It is a general corporate update/announcement that does not fit into the more specific categories, making “Regulatory Filings” (RNS) the appropriate fallback classification.
2026-04-09 English
News release - English.pdf
Regulatory Filings Classification · 80% confidence The document is a press release announcing that Datametrex has received a $6 million purchase order from a Fortune 500 company. It is not a financial report, proxy, management change, or dividend notice, nor does it detail financing (debt or equity issuance) or M&A activity. It is a general corporate announcement with no specific fitting category, so it falls under the fallback category of Regulatory Filings (RNS).
2026-04-09 English
News release - English.pdf
Regulatory Filings Classification · 75% confidence The document is a corporate press release announcing a strategic agreement to support patent monetization. It does not present financial results or raise new capital, nor is it an earnings release, M&A announcement, or regulatory filing of audited financial statements—it’s simply a business update/press release. No category for IP advisory deals exists, so this falls into the general “Regulatory Filings” (fallback) category.
2026-04-08 English
News release - English.pdf
Regulatory Filings Classification · 65% confidence The document is a corporate press release announcing a strategic agreement between Datametrex’s subsidiary and Hilco Global to monetize patents. It contains no financial results, no AGM materials, no dividend or share issuance details, no management/board changes, no earnings call transcript, nor any regulatory stress test or proxy materials. It is a general announcement of a business development and does not match any highly specific category, so it falls into the fallback “Regulatory Filings” category (RNS).
2026-04-08 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.